Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug Substance…
FY2023 · complete year · data as of 2026-07-03
A single federal award, with both ends of the trail linked.
Award 75A50123C00010 is a contract from the Department of Health and Human Services to Albert B. Sabin Vaccine Institute, Inc. (The), $163.1M obligated, FY2023 to FY2030, for Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug…. The work is performed in District Of Columbia. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN42 (Health R&D Services; Health Care - Other; Applied Research). Source
Description
The Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug Substance (BDS) and Final Drug Product (FDP)) to Provide Doses That May Be Used in the Event of an Outbreak Scenario. The Proposed Effort Will Utili